Silicon Investor
SI
SI
Advertise on SI

Profile for harkenman
Add PeopleMarkIgnore MemberSend Private MessageRecent Posts

Site Participation
Date Joined Feb 2 1997 User Level
Posts 635 Boards Moderated2
PeopleMarks 2 Bans Issued 0
Ignored By 0 Bans Received 0

Personal Information
Company: Pharmaceuticals
Occupation/Title: Operations Manager
Age: starting to enjoy life!!
Location: Beach Front (Nice and Warm)
College: Purdue
Degree: Ph.D. Medicinal Chemistry, MBA Finance, BS Chemistry
Favorite Stocks: BRL, CNC, CYTO, CSCO, GTW, IOM, DRMD, AAPL,, OO , REGN, JNJ, PFE, TOPP , ORCL, U, WPI, LU, ELN, CA Shorts CPQ, QCOM, YHOO, CEPH
Investment Style: Buy low, sell high. Semi-Contrarian, Short overvalued stocks and buy oversold stocks. Arbitrage trading. Search for market imperfections
Investment Experience: 11 years, avg 50% on both trades and portafolio
Interests and Hobbies: Windsurfing, Hobie 16 one design class racing, surfing and stock investing.
Quote: Stick to your knittings
Additional Info: Don't worry,be happy. Thanks to the Internet I can live here and trade with the PRO's.
25 Most Recent SubjectsLast PostPosts
Barr Laboratory BRL8/9/2000 72
Biotechnology Value Fund, L.P.3/8/2000 1
LastShadow's Position Trading3/8/2000 1
The Player's Club3/8/2000 1
Joe Copia's daytrades/investments and thoughts3/8/2000 1
Datek Brokerage $9.95 a trade3/8/2000 1
Market Gems:Stocks w/Strong Earnings and High Tech. Rank3/8/2000 9
Buffettology2/25/2000 2
YEAR 2000 STOCK PICKING CONTEST2/25/2000 8
Breakout picks...BEFORE they Breakout!!2/25/2000 2
Picks you can sleep on.2/25/2000 1
Cents and Sensibility - Kimberly and Friends' Consortium2/25/2000 1
Duramed (DRMD) Synthetic Estrogen Product2/23/2000 63
Range Bound & Undervalued Quality Stocks1/13/2000 3
CYTO1/6/2000 40
Compaq1/4/2000 57
Regeneron Pharmaceuticals12/29/1999 13
ONXX10/19/1999 17
OAKLEY- NYSE:OO7/14/1999 27
DRAX - Draxis Health7/5/1999 20
Oracle Corporation (ORCL)6/24/1999 6
BRADLEY PHARMACEUTICALS (BPRXA)6/18/1999 6
TITAN PHARMACEUTICAL (TTP)5/10/1999 2
wla(warner lambert)4/28/1999 3
Novacare (NOV) breaking out...4/28/1999 7
Read Last    Messages  
List Last    Messages  

Posts by harkenman
MessageSubjectRecsPosted
I started this thread 3 years ago and believed in this stock. Since then the stBarr Laboratory BRL8/9/2000
CEPH Insider selling Baldino, Jeffrey CEO; and VAUGHT JEFFRY L, President of CeBiotechnology Value Fund, L.P.3/8/2000
CEPH Insider selling Baldino, Jeffrey CEO; and VAUGHT JEFFRY L, President of CeLastShadow's Position Trading3/8/2000
CEPH Insider selling Baldino and VAUGHT JEFFRY L, President of Cephalon Inc to The Player's Club3/8/2000
CEPH Insider selling Baldino and VAUGHT JEFFRY L, President of Cephalon Inc to Joe Copia's daytrades/investments and thoughts3/8/2000
CEPH Insider selling Baldino and VAUGHT JEFFRY L, President of Cephalon Inc to Datek Brokerage $9.95 a trade3/8/2000
CEPH Insider selling Baldino and VAUGHT JEFFRY L, President of Cephalon Inc toMarket Gems:Stocks w/Strong Earnings and High Tech. Rank3/8/2000
Good analysis. Seems that BRL board will re-ignigt when people realize how undBuffettology2/25/2000
REGN up 383% since pick in December 28. Not bad. YEAR 2000 STOCK PICKING CONTEST2/25/2000
BPRX about to breakout. Did any one play my January 10 recommendation? Link: Market Gems:Stocks w/Strong Earnings and High Tech. Rank2/25/2000
DRMD (Nasdaq) Earnings (mid March 2000) breakout on sales for conjugated estrogBreakout picks...BEFORE they Breakout!!2/25/2000
BRL (NYSE) $1 billion+ Prozac patent challenge March 8 Fedl Appeals Court To HePicks you can sleep on.2/25/2000
BRL (NYSE) $1 billion+ Prozac patent challenge March 8 Fedl Appeals Court To HeBuffettology2/25/2000
BRL (NYSE) $1 billion+ Prozac patent challenge March 8 Fedl Appeals Court To HeCents and Sensibility - Kimberly and Friends' Consortium2/25/2000
BRL (NYSE) $1 billion+ Prozac patent challenge March 8 Fedl Appeals Court To HMarket Gems:Stocks w/Strong Earnings and High Tech. Rank2/25/2000
BRL (NYSE) $1 billion+ Prozac patent challenge March 8 Fedl Appeals Court To Breakout picks...BEFORE they Breakout!!2/25/2000
Fedl Appeals Court To Hear Prozac Patent Challenge March 8 POMONA, N.Y. -- TheBarr Laboratory BRL2/25/2000
Why todays drop? Duramed (DRMD) Synthetic Estrogen Product2/23/2000
DRMD stock to break out in March after earnings announcement Market Gems:Stocks w/Strong Earnings and High Tech. Rank2/16/2000
DRMD is another stock to break out in March with strong fundamentals. I expectMarket Gems:Stocks w/Strong Earnings and High Tech. Rank2/16/2000
Did you buy CYTO which I recommended On Jan 10 up 1000% for the year? Link: SI Market Gems:Stocks w/Strong Earnings and High Tech. Rank2/16/2000
DRMD took a large charge for start-up of Cenestin last Q in addition to $7.5MilDuramed (DRMD) Synthetic Estrogen Product2/7/2000
SEC report dated 1-31-00 on closure of Schein deal pending financing of debt. Duramed (DRMD) Synthetic Estrogen Product2/7/2000
When are earnings scheduled to be reported? When are AHP earnings scheduled? Duramed (DRMD) Synthetic Estrogen Product1/21/2000
BRL Stock closed up today 4 1/4. Seems that the pharma sector is getting the atYEAR 2000 STOCK PICKING CONTEST1/13/2000
Stock closed up today 4 1/4. Seems that the pharma sector is getting the attenBarr Laboratory BRL1/13/2000
The Wall Street Transcript Publishes Management Performance Review in Emerging Range Bound & Undervalued Quality Stocks1/13/2000
Check TEVA, ALO, MYL, BRL, WPI, ELN CBS Market watch cbs.marketwatch.com  Range Bound & Undervalued Quality Stocks1/13/2000
Check BRL Pharm sector (generics) PE 15. Strong research and undervalued by aRange Bound & Undervalued Quality Stocks1/13/2000
What is surprising the number of shorts that this stock has. This is whats keeDuramed (DRMD) Synthetic Estrogen Product1/12/2000
What is you estimate for earnings this Q? Do you expect a run up this Q or nexDuramed (DRMD) Synthetic Estrogen Product1/12/2000
brl is another of my favorites pharma companies which sector has received a lotMarket Gems:Stocks w/Strong Earnings and High Tech. Rank1/10/2000
bprx is another play which is having a lot of trading activity lately and favorMarket Gems:Stocks w/Strong Earnings and High Tech. Rank1/10/2000
CYTO is a buy with lots of activity and coverage in Bloomberg and WSJ. FundameMarket Gems:Stocks w/Strong Earnings and High Tech. Rank1/10/2000
Have you done an analysis and can you point me under which message you posted. Duramed (DRMD) Synthetic Estrogen Product1/10/2000
DRAX  YEAR 2000 STOCK PICKING CONTEST1/10/2000
Vestor, has anyone done a stock valuation for DRMD based on fundamentals, drug Duramed (DRMD) Synthetic Estrogen Product1/10/2000
PGNX: Increasing Price Target to $30 from $20; Maintain Strong Buy Rating PrCYTO1/6/2000
This agrees with BW article in which Internet is their strategy. How can you bCompaq1/4/2000
News came out today that CPQ is holding at 11% market share. Would you interprCompaq1/3/2000
Good analysis on earnings. CPQ sales are higher than DELL. I'm only conceCompaq12/31/1999
When do you expect for it to hit $18 to cover my short at $30? One week beforeCompaq12/31/1999
Okay. But please put me down as the second who recommended DRMD. It really isYEAR 2000 STOCK PICKING CONTEST12/30/1999
My mistake. Even though I do recommend REGN as a winner I just today realized YEAR 2000 STOCK PICKING CONTEST12/29/1999
Katie: REGN up today 19% on 184K (negligible) volume. Yesterday up 13% ConsideYEAR 2000 STOCK PICKING CONTEST12/29/1999
19% increase in one day. Not bad! Regeneron Pharmaceuticals12/29/1999
Yes. I am picking REGN for the contest.  YEAR 2000 STOCK PICKING CONTEST12/28/1999
REGN 13% increase at todays closing. Still a buy withh upside potential. YEAR 2000 STOCK PICKING CONTEST12/27/1999
Huge percent change will trigger the momentum players. I believe stock will hiRegeneron Pharmaceuticals12/27/1999
Where do you get your numbers from? Trade journals (i.e. IMS) or are you an inDuramed (DRMD) Synthetic Estrogen Product12/27/1999
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.